Beyond Air (XAIR) Profit After Tax (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Beyond Air | 3.27 Mn | -6.59 Mn | 300,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.60% |
| Sep 30, 2025 | -2.23% |
| Jun 30, 2025 | 18.31% |
| Mar 31, 2025 | 25.84% |
| Dec 31, 2024 | 4.96% |
| Sep 30, 2024 | -7.46% |
| Jun 30, 2024 | 26.49% |
| Mar 31, 2024 | -9.49% |
| Dec 31, 2023 | 6.92% |
| Sep 30, 2023 | -15.75% |
| Jun 30, 2023 | -184.11% |
| Mar 31, 2023 | 229.73% |
| Dec 31, 2022 | -7.82% |
| Sep 30, 2022 | -9.81% |
| Jun 30, 2022 | -364.86% |
| Mar 31, 2022 | 156.85% |
| Dec 31, 2021 | 10.96% |
| Sep 30, 2021 | -28.90% |
| Jun 30, 2021 | -28.88% |
| Mar 31, 2021 | 9.32% |
| Dec 31, 2020 | -12.43% |
| Sep 30, 2020 | 23.88% |
| Jun 30, 2020 | -27.97% |
| Mar 31, 2020 | -19.85% |
| Dec 31, 2019 | -7.27% |
| Sep 30, 2019 | 33.70% |
| Jun 30, 2019 | -8,597.54% |
| Mar 31, 2019 | 97.00% |
| Dec 31, 2018 | 1.50% |
| Sep 30, 2018 | -39.82% |
| Jun 30, 2018 | -264.01% |
| Mar 31, 2018 | 160.43% |
| Dec 31, 2017 | 75.75% |
| Sep 30, 2017 | -148.23% |
| Jun 30, 2017 | 54.14% |
| Mar 31, 2017 | -544.79% |
| Dec 31, 2016 | -93.64% |
| Sep 30, 2016 | 48.14% |
| Jun 30, 2016 | 23.80% |